EUVIMEDEUVIMED entdecken
Multizentrische Studie

US-guided Nanosecond Pulsed Electric Field Ablation of Low-risk PTMC: Interim Results of a Prospective Multicenter Study

Xiao-Long Li, Li-Yu Chen, Kai-Yuan Shi, Pei-Li Fan, Xin-Ran Tang, Jian-Hua Fang, Xiao-Peng Yan, Ying-Xia Zhang, Yun-Jie Jin, Zheng-Biao Ji, Li-Ping Sun, Gang Dong iD und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf706 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Xiao-Long Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary, Ultrasonography, Interventional. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Nanosecond pulsed electric field (nsPEF) ablation has gradually been applied in clinical practice. However, no studies have reported its application in low-risk papillary thyroid microcarcinoma (PTMC).

Objective

The study aimed to evaluate the efficacy and safety of nsPEF ablation for patients with low-risk PTMC.

Methods

This prospective study (Chinese Clinical Trial Register: ChiCTR-2200064902) included consecutive low-risk patients with PTMC who underwent nsPEF ablation at 6 hospitals in China. Technical feasibility was assessed by recording the technical success of the procedure and therapeutic efficacy at the 1-, 3-, 6-, and 12-month follow-up. Technical success was evaluated using contrast-enhanced ultrasound immediately after ablation, where the target ablation zone exceeded the tumor edge. Therapeutic complications were evaluated.

Results

From September 2022 to September 2024, 85 patients (median age, 38 years; interquartile range, 32-47 years; 58 females) with 85 PTMCs were included, all achieving successful nsPEF ablation. At 1-, 3-, 6-, and 12-month follow-up, median tumor volumes were 0.109, 0.054, 0.020, and 0.000 mL, and the associated median volume reduction ratios were −124.0%, −4.8%, 63.5%, and 100%, respectively. At 12 months, 88.0% (66/75) of PTMCs achieved complete disappearance. Fifty-six (65.9%) patients experienced transient thyrotoxicosis. No recurrent tumors, cervical lymph node metastasis, or distant metastasis were observed during follow-up. Conclusion nsPEF ablation under general anesthesia for low-risk PTMC is effective and safe, with the only major complication being transient thyrotoxicosis in more than 50% of patients, which might be caused by the release of thyroid hormones into the bloodstream because of irreversible electroporation. It appears to offer better absorption of the ablated lesions in the short term, potentially increasing its clinical use. Further short- and long-term study is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryUltrasonography, InterventionalHumansFemaleMaleMiddle AgedAdultProspective StudiesTreatment OutcomeFollow-Up StudiesChinaAblation TechniquesUltrasonography

Stichwörter der Autor:innen

efficacynanosecond pulsed electric field ablationpapillary thyroid microcarcinomasafetyultrasound

Autor:innen und Institutionen

  • Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • Ultrasound Imaging Department, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang 310006, China.
  • Ultrasound Imaging Department, The Second Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, China.
  • Ultrasound Imaging Department, The Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, Inner Mongolia 010030, China.
  • Department of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, Sc…

ORCID-Profile: Gang Dong, Hui-Xiong Xu

Zitieren

APA

Li, X. L., Chen, L. Y., Shi, K. Y., Fan, P. L., Tang, X. R., Fang, J. H., Yan, X. P., Zhang, Y. X., Jin, Y. J., Ji, Z. B., Sun, L. P., Dong, G., & Xu, H. X. (2026). US-guided Nanosecond Pulsed Electric Field Ablation of Low-risk PTMC: Interim Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf706

Vancouver

Li XL, Chen LY, Shi KY, Fan PL, Tang XR, Fang JH, et al. US-guided Nanosecond Pulsed Electric Field Ablation of Low-risk PTMC: Interim Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf706

BibTeX
@article{Li2026,
  author = {Li, Xiao-Long and Chen, Li-Yu and Shi, Kai-Yuan and Fan, Pei-Li and Tang, Xin-Ran and Fang, Jian-Hua and Yan, Xiao-Peng and Zhang, Ying-Xia and Jin, Yun-Jie and Ji, Zheng-Biao and Sun, Li-Ping and Dong, Gang and Xu, Hui-Xiong},
  title = {US-guided Nanosecond Pulsed Electric Field Ablation of Low-risk PTMC: Interim Results of a Prospective Multicenter Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf706}
}
Kostenlos starten →